News Room

April 2021 - BioCurity files a US Provisional patent application drawn to pharmaceutical formulations of cerium oxide nanoparticles designed to prevent radiation therapy side effects for cancer patients undergoing radiation therapy

April 2021 - BioCurity receives Notice of Allowance for US patent application

April 2021 - BioCurity receives an issuance from the Australian Patent Office

March 2021 - BioCurity receives an issuance from the Hong Kong Patent Office

January 2021 - BioCurity engages CSSi LifeSciences as lead clinical advisor for its supportive oncology care drugs under development

October 2020 - BioCurity receives an issuance from the European Patent Office

May 2020 - BioCurity receives a 'Decision to Grant a Patent' from the Japan Patent Office

September 2019 - BioCurity receives an issuance from the Chinese Patent Office

02.22.2020 - Angels & Entrepreneurs Retreat

BioCurity was selected as one of the few companies having an opportunity to present at the Angels & Entrepreneurs Retreat. 

01.23.2020 - BDB Breakfast Event

BioCurity was invited to the monthly BDB Breakfast, which surrounded Women Founders of impactful and successful businesses in their industries!

 

01.09.2020 - Business Journal Press Release

The South Florida Business Journal issued a Press Release about BioCurity's Reg CF offering!

01.08.2020 - BDB Press Release

The Palm Beach Business Development Board (BDB) issued a Press Release about BioCurity's Reg CF offering!

Media Vault

01.23.2020

BDB Breakfast Event

Dr. Cheryl Baker, PhD, Scientific Co-Founder of BioCurity spoke to the attendees about BioCurity and the company's vision.

 

See pictures from the event, below:

Print Print | Sitemap
© 2021 BioCurity Pharmaceuticals Inc. All Rights Reserved.